318 related articles for article (PubMed ID: 11278695)
21. The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors.
Huang TT; Feinberg SL; Suryanarayanan S; Miyamoto S
Mol Cell Biol; 2002 Aug; 22(16):5813-25. PubMed ID: 12138192
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates.
Besnard-Guerin C; Belaïdouni N; Lassot I; Segeral E; Jobart A; Marchal C; Benarous R
J Biol Chem; 2004 Jan; 279(1):788-95. PubMed ID: 14561767
[TBL] [Abstract][Full Text] [Related]
23. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
Estrabaud E; Le Rouzic E; Lopez-Vergès S; Morel M; Belaïdouni N; Benarous R; Transy C; Berlioz-Torrent C; Margottin-Goguet F
PLoS Pathog; 2007 Jul; 3(7):e104. PubMed ID: 17676996
[TBL] [Abstract][Full Text] [Related]
24. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum.
Binette J; Dubé M; Mercier J; Halawani D; Latterich M; Cohen EA
Retrovirology; 2007 Oct; 4():75. PubMed ID: 17937819
[TBL] [Abstract][Full Text] [Related]
25. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.
Mitchell RS; Katsura C; Skasko MA; Fitzpatrick K; Lau D; Ruiz A; Stephens EB; Margottin-Goguet F; Benarous R; Guatelli JC
PLoS Pathog; 2009 May; 5(5):e1000450. PubMed ID: 19478868
[TBL] [Abstract][Full Text] [Related]
26. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V
PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691
[TBL] [Abstract][Full Text] [Related]
28. All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex.
Heilker R; Freuler F; Pulfer R; Di Padova F; Eder J
Eur J Biochem; 1999 Jan; 259(1-2):253-61. PubMed ID: 9914500
[TBL] [Abstract][Full Text] [Related]
29. NF-κB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-κB activation.
Neidel S; Ren H; Torres AA; Smith GL
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5699-5704. PubMed ID: 30819886
[TBL] [Abstract][Full Text] [Related]
30. Rotavirus NSP1 Requires Casein Kinase II-Mediated Phosphorylation for Hijacking of Cullin-RING Ligases.
Davis KA; Morelli M; Patton JT
mBio; 2017 Aug; 8(4):. PubMed ID: 28851847
[TBL] [Abstract][Full Text] [Related]
31. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.
Ganesh L; Burstein E; Guha-Niyogi A; Louder MK; Mascola JR; Klomp LW; Wijmenga C; Duckett CS; Nabel GJ
Nature; 2003 Dec; 426(6968):853-7. PubMed ID: 14685242
[TBL] [Abstract][Full Text] [Related]
32. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
[TBL] [Abstract][Full Text] [Related]
33. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB; Harhaj E; Sun SC
Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
[TBL] [Abstract][Full Text] [Related]
34. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases.
Bossis G; Salinas S; Cartier C; Devaux C; Briant L
FEBS Lett; 2002 Apr; 516(1-3):257-64. PubMed ID: 11959143
[TBL] [Abstract][Full Text] [Related]
36. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.
Yaron A; Hatzubai A; Davis M; Lavon I; Amit S; Manning AM; Andersen JS; Mann M; Mercurio F; Ben-Neriah Y
Nature; 1998 Dec; 396(6711):590-4. PubMed ID: 9859996
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
38. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
[TBL] [Abstract][Full Text] [Related]
39. Regulation of NF-κB by ubiquitination and degradation of the IκBs.
Kanarek N; Ben-Neriah Y
Immunol Rev; 2012 Mar; 246(1):77-94. PubMed ID: 22435548
[TBL] [Abstract][Full Text] [Related]
40. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
Yin L; Laevsky G; Giardina C
J Biol Chem; 2001 Nov; 276(48):44641-6. PubMed ID: 11572859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
